Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$537M |
| 2 |
Peloton Interactive
PTON
|
+$373M |
| 3 |
Amazon
AMZN
|
+$306M |
| 4 |
S&P Global
SPGI
|
+$244M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$232M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$1.27B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$744M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$716M |
| 4 |
AbbVie
ABBV
|
+$712M |
| 5 |
Pinduoduo
PDD
|
+$542M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 16.67% |
| 3 | Consumer Discretionary | 11.17% |
| 4 | Communication Services | 10.86% |
| 5 | Consumer Staples | 10.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALIM
2676
DELISTED
Alimera Sciences
ALIM
| $697K | ﹤0.01% |
165,207
+46,603
| +39% | +$209K |
|
|
CTO
2677
CTO Realty Growth
CTO
$817M
| $695K | ﹤0.01% |
49,464
-93,844
| -65% | -$1.24M |
|
2678
InflaRx
IFRX
$261M
| $695K | ﹤0.01% |
+138,100
| New | +$622K |
|
|
KREF
2679
KKR Real Estate Finance Trust
KREF
$464M
| $692K | ﹤0.01% |
38,600
+19,300
| +100% | +$341K |
|
2680
Jakks Pacific
JAKK
$297M
| $691K | ﹤0.01% |
138,804
+37,205
| +37% | +$176K |
|
2681
Global X MSCI China Consumer Discretionary ETF
CHIQ
$129M
| $690K | ﹤0.01% |
+19,392
| New | +$622K |
|
2682
Solitario Resources
XPL
$68.9M
| $689K | ﹤0.01% |
1,224,584
+286,956
| +31% | +$135K |
|
|
KZIA
2683
Kazia Therapeutics
KZIA
$137M
| $688K | ﹤0.01% |
1,593
+42
| +3% | +$16.7K |
|
2684
Stagwell
STGW
$2.16B
| $688K | ﹤0.01% |
273,954
+85,134
| +45% | +$190K |
|
2685
First Trust North American Energy Infrastructure Fund
EMLP
$4.08B
| $686K | ﹤0.01% |
+32,700
| New | +$679K |
|
|
BXG
2686
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
| $686K | ﹤0.01% |
86,400
+24,300
| +39% | +$145K |
|
|
FRTX
2687
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $685K | ﹤0.01% |
19,511
+5,774
| +42% | +$181K |
|
|
FSFG
2688
DELISTED
First Savings Financial Group
FSFG
| $676K | ﹤0.01% |
31,200
+900
| +3% | +$18K |
|
|
AFBI
2689
DELISTED
Affinity Bancshares
AFBI
| $673K | ﹤0.01% |
61,552
+5,595
| +10% | +$53.2K |
|
|
BLRX
2690
BioLineRX
BLRX
$11.8M
| $673K | ﹤0.01% |
6,675
-7
| -0.1% | -$612 |
|
|
VYNT
2691
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $673K | ﹤0.01% |
48,560
+9,880
| +26% | +$146K |
|
|
NEOS
2692
DELISTED
Neos Therapeutics, Inc
NEOS
| $673K | ﹤0.01% |
1,076,683
+115,783
| +12% | +$71.5K |
|
2693
ResMed
RMD
$32.5B
| $672K | ﹤0.01% |
3,207
-9,893
| -76% | -$1.97M |
|
2694
South Plains Financial
SPFI
$854M
| $671K | ﹤0.01% |
+35,404
| New | +$590K |
|
2695
RBB Bancorp
RBB
$456M
| $670K | ﹤0.01% |
43,591
-28,600
| -40% | -$406K |
|
|
REVG
2696
DELISTED
REV Group
REVG
| $670K | ﹤0.01% |
+76,000
| New | +$677K |
|
|
FLY
2697
DELISTED
Fly Leasing Limited
FLY
| $670K | ﹤0.01% |
+67,980
| New | +$531K |
|
2698
Eledon Pharmaceuticals
ELDN
$266M
| $666K | ﹤0.01% |
43,251
+1,132
| +3% | +$21.6K |
|
2699
VanEck Gold Miners ETF
GDX
$25.5B
| $666K | ﹤0.01% |
18,500
-93,500
| -83% | -$3.49M |
|
2700
SIFCO Industries
SIF
$169M
| $666K | ﹤0.01% |
79,234
+6,500
| +9% | +$26.3K |
|
Similar funds
Renaissance Technologies's Q4 2020 Portfolio in Review
As of Q4 2020, Renaissance Technologies held 3,901 positions worth $92.1B, down 8% from $100B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Renaissance Technologies withdrew a net $21.6B in Q4 2020, closing 555 positions and reducing 1,622 holdings. Its most notable exit was Charter Communications, an estimated $341M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in NVIDIA worth $524M.
- Renaissance Technologies's largest Q4 2020 buy was NVIDIA: 40,123,720 shares worth $524M.
- Renaissance Technologies added most to Amazon in Q4 2020, an estimated $306M increase.
- Renaissance Technologies's biggest Q4 2020 reduction was Zoom, cutting an estimated $1.27B.
- Renaissance Technologies fully exited Charter Communications in Q4 2020, selling an estimated $341M.
- Renaissance Technologies's ten largest holdings make up 13% of its $92.1B portfolio in Q4 2020.
- Renaissance Technologies opened 565 new positions and closed 555 in Q4 2020.
- Renaissance Technologies's portfolio value fell 8% quarter-over-quarter to $92.1B.
Based on Renaissance Technologies's 13F filing for Q4 2020, filed 10 Feb 2021.